Iniciar Sessão

Notícias e actividades

Cientistas portugueses já sequenciaram mais de 370 genomas do novo coronavírus

Covid-19 obriga ao fecho de quase 100 extensões de saúde

ncase - What Happens Next? COVID-19 Futures, Explained With Playable Simulations

ncase"The only thing to fear is fear itself" was stupid advice.Sure, don't hoard toilet paper – but if policymakers fear fear itself, they'll downplay real dangers to avoid "mass panic". Fear's not the problem, it's how we channel our fear. Fear...

NEJM - Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

The New England Journal of MedicineThere is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral...

NEJM - Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

The New England Journal of MedicineA potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well studied.

NEJM - Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

The New England Journal of MedicineCoronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting–enzyme (ACE)...

THE LANCET - Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside analogue prodrug, has inhibitory effects on pathogenic animal and human...